Treatment with Candesartan Combined with Angiotensin-Converting Enzyme Inhibitor for Immunosuppressive Treatment-Resistant Nephrotic Syndrome after Allogeneic Stem Cell Transplantation

• OSUGI Yuko

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

• YAMADA Hiroshi

  Department of Pediatrics, Osaka City General Hospital

• HOSOI Gaku

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

• NOMA Haruyoshi

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

• IKEMIYA Misako

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

• ISHII Takefumi

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

• SAKO Masahiro

  Department of Pediatric Hematology/Oncology, Osaka City General Hospital

収録刊行物

• International journal of hematology

  International journal of hematology 83 (5), 454-458, 2006-06-15

キーワード

• Nephrotic syndrome
• Allogeneic stem cell transplantation
• Chronic GVHD
• Membranous nephropathy
• Angiotensin-converting enzyme inhibitor
• Candesartan
• Angiotensin II receptor blocker

詳細情報

• CRID: 1572261550278374784
• NII論文ID: 10018141357
• NII書誌ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2007094123
• 本文言語コード: en
• データソース種別:
  • CiNii Articles